Patents by Inventor Kye Won Park

Kye Won Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating, managing, inhibiting, or preventing obesity
    Patent number: 9877946
    Abstract: A composition for inducing differentiation into beige adipocytes from white adipocytes, including butein, a butein derivative, or a pharmaceutically available salt thereof as an active ingredient, and a method of inducing the differentiation are provided. Increases in expressions of UCP-1 and PRDM4 are confirmed using the active ingredient, that is, the butein or butein derivative, and therefore the composition is expected to be used in preventing or treating obesity, and more basically, for target treatment.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: January 30, 2018
    Assignees: Research & Business Foundation Sungkyunkwan University, GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR
    Inventors: Kye Won Park, Nojoon Song, Suk Chan Lee, Jin-Mo Ku
  • COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME
    Publication number: 20170087126
    Abstract: A composition for inducing differentiation into beige adipocytes from white adipocytes, including butein, a butein derivative, or a pharmaceutically available salt thereof as an active ingredient, and a method of inducing the differentiation are provided. Increases in expressions of UCP-1 and PRDM4 are confirmed using the active ingredient, that is, the butein or butein derivative, and therefore the composition is expected to be used in preventing or treating obesity, and more basically, for target treatment.
    Type: Application
    Filed: December 9, 2016
    Publication date: March 30, 2017
    Applicants: RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVER SITY, GYEONGGI INSTITUTE OF SCIENCE & TECHNOLOGY PROMOTI ON
    Inventors: Kye Won PARK, Nojoon SONG, Suk Chan LEE, Jin-Mo KU
  • Composition for inducing differentiation into beige and brown adipocytes and method of inducing the same
    Patent number: 9549908
    Abstract: A composition for inducing differentiation into beige adipocytes from white adipocytes, including butein, a butein derivative, or a pharmaceutically available salt thereof as an active ingredient, and a method of inducing the differentiation are provided. Increases in expressions of UCP-1 and PRDM4 are confirmed using the active ingredient, that is, the butein or butein derivative, and therefore the composition is expected to be used in preventing or treating obesity, and more basically, for target treatment.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: January 24, 2017
    Assignees: Research & Business Foundation Sungkyunkwan University, Ltd., Gyeonggi Institute of Science & Technology Promotion
    Inventors: Kye Won Park, Nojoon Song, Suk Chan Lee, Jin-Mo Ku
  • COMPOSITION FOR PREVENTING OR TREATING EDEMA CONTAINING FLAVONOID COMPOUND
    Publication number: 20160081974
    Abstract: Provided is a method of treating edema using a flavonoid compound or a pharmaceutically acceptable salt thereof, and by the method, acquired edema triggered due to cancer treatments can be cured. A composition containing the flavonoid compound is a chemical approach to a conventional physical treatment method, and when the composition is administered to an edema-induced mouse, a considerable reduction in size of edema is observed.
    Type: Application
    Filed: September 18, 2015
    Publication date: March 24, 2016
    Applicant: Research & Business Foundation SUNGKYUNKWAN UNIVERSITY
    Inventors: Suk Chan LEE, Kye Won PARK, Kangsan ROH, Nojoon SONG, Jaehyun PARK
  • COMPOSITION FOR INDUCING DIFFERENTIATION INTO BEIGE AND BROWN ADIPOCYTES AND METHOD OF INDUCING THE SAME
    Publication number: 20150374643
    Abstract: A composition for inducing differentiation into beige adipocytes from white adipocytes, including butein, a butein derivative, or a pharmaceutically available salt thereof as an active ingredient, and a method of inducing the differentiation are provided. Increases in expressions of UCP-1 and PRDM4 are confirmed using the active ingredient, that is, the butein or butein derivative, and therefore the composition is expected to be used in preventing or treating obesity, and more basically, for target treatment.
    Type: Application
    Filed: June 22, 2015
    Publication date: December 31, 2015
    Applicants: RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY, GYEONGGI INSTITUTE OF SCIENCE & TECHNOLOGY PROMOTION
    Inventors: Kye Won PARK, Nojoon SONG, Suk Chan LEE, Jin-Mo KU
  • METHODS AND COMPOSITIONS FOR MANIPULATING THE GUIDED NAVIGATION OF ENDOTHELIAL TUBES DURING ANGIOGENESIS
    Publication number: 20130143320
    Abstract: Methods and compositions for manipulating the directed navigation of physiological tracking tubular structures are provided. A novel cell-bound receptor, roundabout-4 (Robo-4), is described. The Robo-4 receptor shows sequence and structural similarity to members of the roundabout family of receptors. Also, the Robo-4 receptor binds Slit ligand, a known receptor of the roundabout receptors. Polynucleotides and polypeptides of the Robo-4 receptor are described.
    Type: Application
    Filed: October 23, 2012
    Publication date: June 6, 2013
    Applicant: University of Utah Research Foundation
    Inventors: Dean Y. Li, Kye Won Park
  • METHODS AND COMPOSITIONS FOR MANIPULATING THE GUIDED NAVIGATION OF ENDOTHELIAL TUBES DURING ANGIOGENESIS
    Publication number: 20110189769
    Abstract: Methods and compositions for manipulating the directed navigation of physiological tracking tubular structures are provided. A novel cell-bound receptor, roundabout-4 (Robo-4), is described. The Robo-4 receptor shows sequence and structural similarity to members of the roundabout family of receptors. Also, the Robo-4 receptor binds Slit ligand, a known receptor of the roundabout receptors. Polynucleotides and polypeptides of the Robo-4 receptor are described.
    Type: Application
    Filed: December 21, 2010
    Publication date: August 4, 2011
    Applicant: UNIVERSITY OF UTAH RESEARCH FOUNDATION
    Inventors: Dean Y. Li, Kye Won Park
  • Promoting angiogenesis with netrin1 polypeptides
    Patent number: 7456151
    Abstract: The present invention provides methods and compositions for modulating proliferation, differentiation, migration, and adhesion of cardiovascular cell types.
    Type: Grant
    Filed: July 14, 2005
    Date of Patent: November 25, 2008
    Assignee: University of Utah Research Foundation
    Inventors: Dean Y. Li, Kye Won Park